HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Schlemmer Selected Research

(meso- 1,2- bis- (2,6- dichloro- 4- hydroxyphenyl)ethylenediamine)dichloroplatinum(II)

10/2001Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Schlemmer Research Topics

Disease

5Breast Neoplasms (Breast Cancer)
10/2001 - 03/2000
4Neoplasms (Cancer)
10/2001 - 12/2000

Drug/Important Bio-Agent (IBA)

4ethylenediamine (ethylenediamine dihydroiodide)FDA Link
10/2001 - 03/2000
3Hormones (Hormone)IBA
04/2001 - 03/2000
3Immunologic Factors (Immunomodulators)IBA
04/2001 - 03/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001 - 12/2000
2PlatinumIBA
10/2001 - 04/2001
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2001 - 12/2000
1(meso- 1,2- bis- (2,6- dichloro- 4- hydroxyphenyl)ethylenediamine)dichloroplatinum(II)IBA
10/2001
1Pharmaceutical PreparationsIBA
10/2001
1Estrogen ReceptorsIBA
10/2001
1DNA (Deoxyribonucleic Acid)IBA
10/2001
1Estrogens (Estrogen)FDA Link
04/2001
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2000

Therapy/Procedure

1Therapeutics
04/2001
1Splenectomy
12/2000